R&D Progress

TE-6168 drug development was selected as a significant case of the Center for Drug Evaluation (CDE), Taiwan

March 3, 2026

“The development of TE-6168, the novel thrombolytic fusion protein” was selected as a significant case of the Center for Drug […]

Address: Room C520, Building C, No. 99, Lane 130, Sec. 1, Academia Rd, Nangang District, Taipei City, Taiwan R.O.C. 115021

Email: or
Phone: +886-2-2651-2268

Scroll to Top